• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CXCL12/CXCR4 轴在实体瘤微环境中的作用:转移的关键介质。

CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis.

机构信息

Department of Anatomy, School of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.

出版信息

Life Sci. 2020 May 15;249:117534. doi: 10.1016/j.lfs.2020.117534. Epub 2020 Mar 7.

DOI:10.1016/j.lfs.2020.117534
PMID:32156548
Abstract

Tumors are dynamic tissue masses, so requiring continuous exposure to the host cells, nurturing them into pave a path for tumor growth and metastasis. C-X-C chemokine ligand 12 (CXCL12)/C-X-C chemokine receptor type 4 (CXCR4) is the key signaling for such aim. Gathering knowledge about the activity within this axis would deepen our insight into the utmost importance this signaling taken to attract and cross-connect multiple cells within the tumor microenvironment (TME) aiming for tumor progression and metastasis. The concept behind this review is to underscore the multi-tasking roles taken by CXCL12/CXCR4 signaling in tumor metastasis, and to also suggest some strategies to target the activities within this axis.

摘要

肿瘤是动态的组织肿块,因此需要持续暴露于宿主细胞中,滋养它们,为肿瘤生长和转移铺平道路。C-X-C 趋化因子配体 12(CXCL12)/C-X-C 趋化因子受体 4(CXCR4)是实现这一目标的关键信号。了解该轴中的活性将加深我们对这种信号在吸引和连接肿瘤微环境(TME)中的多种细胞以促进肿瘤进展和转移方面的重要性的认识。这篇综述的概念是强调 CXCL12/CXCR4 信号在肿瘤转移中所扮演的多任务角色,并提出一些针对该轴中活性的靶向策略。

相似文献

1
CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis.CXCL12/CXCR4 轴在实体瘤微环境中的作用:转移的关键介质。
Life Sci. 2020 May 15;249:117534. doi: 10.1016/j.lfs.2020.117534. Epub 2020 Mar 7.
2
The role of CXCL12 in tumor microenvironment.CXCL12在肿瘤微环境中的作用。
Gene. 2018 Jan 30;641:105-110. doi: 10.1016/j.gene.2017.10.015. Epub 2017 Oct 7.
3
A review on CXCR4/CXCL12 axis in oncology: no place to hide.CXCR4/CXCL12 轴在肿瘤学中的研究进展:无处可藏。
Eur J Cancer. 2013 Jan;49(1):219-30. doi: 10.1016/j.ejca.2012.05.005. Epub 2012 Jun 9.
4
The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow.趋化因子受体CXCR4/CXCR7及其主要异二聚体配体CXCL12和CXCL12/高迁移率族蛋白盒1在胰腺癌生长和发展中的作用:探索进展
Pancreas. 2015 May;44(4):528-34. doi: 10.1097/MPA.0000000000000298.
5
CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks.CXCL12/CXCR4:致癌通讯网络中连接癌细胞与其基质邻域的共生桥梁。
Oncogene. 2016 Feb 18;35(7):816-26. doi: 10.1038/onc.2015.139. Epub 2015 May 11.
6
[Correlations of chemokine CXCL12 and its receptor to tumor metastasis].趋化因子CXCL12及其受体与肿瘤转移的相关性
Ai Zheng. 2007 Feb;26(2):220-4.
7
Molecular Pathways: Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment.分子途径:靶向 CXCR4-CXCL12 轴——肿瘤微环境中的未开发潜力。
Clin Cancer Res. 2015 Oct 1;21(19):4278-85. doi: 10.1158/1078-0432.CCR-14-0914. Epub 2015 Jul 21.
8
CXCR4 Ligands: The Next Big Hit?CXCR4配体:下一个热门靶点?
J Nucl Med. 2017 Sep;58(Suppl 2):77S-82S. doi: 10.2967/jnumed.116.186874.
9
The CXCL12-CXCR4 Signaling Axis Plays a Key Role in Cancer Metastasis and is a Potential Target for Developing Novel Therapeutics against Metastatic Cancer.CXCL12-CXCR4 信号轴在癌症转移中发挥着关键作用,是开发针对转移性癌症的新型治疗药物的潜在靶点。
Curr Med Chem. 2020;27(33):5543-5561. doi: 10.2174/0929867326666191113113110.
10
Role of CXCL12/CXCR4 signaling axis in pancreatic cancer.CXCL12/CXCR4 信号轴在胰腺癌中的作用。
Chin Med J (Engl). 2013;126(17):3371-4.

引用本文的文献

1
Identification and validation of genes related to stem cells and telomere maintenance mechanisms as biomarkers for breast cancer.鉴定和验证与干细胞及端粒维持机制相关的基因作为乳腺癌生物标志物
Front Immunol. 2025 Jul 1;16:1618193. doi: 10.3389/fimmu.2025.1618193. eCollection 2025.
2
Cancer-Associated Fibroblasts: Heterogeneity, Cancer Pathogenesis, and Therapeutic Targets.癌症相关成纤维细胞:异质性、癌症发病机制及治疗靶点
MedComm (2020). 2025 Jul 11;6(7):e70292. doi: 10.1002/mco2.70292. eCollection 2025 Jul.
3
Identifying conserved metastatic pathways across cancers through integrated transcriptomic and network analysis.
通过整合转录组学和网络分析来识别跨癌症的保守转移途径。
Med Oncol. 2025 Jul 10;42(8):321. doi: 10.1007/s12032-025-02902-2.
4
The role of the CXC chemokine family in endometriosis research and its therapeutic potential.CXC趋化因子家族在子宫内膜异位症研究中的作用及其治疗潜力。
J Mol Histol. 2025 Jun 28;56(4):211. doi: 10.1007/s10735-025-10512-5.
5
Global hotspots and trends in pre-metastatic niche research: a bibliometric analysis(2005-2024).转移前生态位研究的全球热点与趋势:一项文献计量分析(2005 - 2024年)
Front Immunol. 2025 May 29;16:1552053. doi: 10.3389/fimmu.2025.1552053. eCollection 2025.
6
Tumor hypoxia shapes natural killer cell anticancer activities.肿瘤缺氧塑造自然杀伤细胞的抗癌活性。
J Mol Med (Berl). 2025 May 30. doi: 10.1007/s00109-025-02557-6.
7
Targeting the chemokine receptor CXCR4 for cancer therapies.以趋化因子受体CXCR4为靶点进行癌症治疗。
Biomark Res. 2025 May 1;13(1):68. doi: 10.1186/s40364-025-00778-y.
8
The Role of Long Non-Coding RNAs in Modulating the Immune Microenvironment of Triple-Negative Breast Cancer: Mechanistic Insights and Therapeutic Potential.长链非编码RNA在调节三阴性乳腺癌免疫微环境中的作用:机制见解与治疗潜力
Biomolecules. 2025 Mar 20;15(3):454. doi: 10.3390/biom15030454.
9
Expression of CXCR4 in the Primary Lesion of Recurrent Metastatic Breast Cancer and Its Association With Prognosis.CXCR4在复发性转移性乳腺癌原发灶中的表达及其与预后的关系。
Int J Gen Med. 2025 Mar 18;18:1543-1553. doi: 10.2147/IJGM.S511426. eCollection 2025.
10
Expanding the horizon of CAR T cell therapy: from cancer treatment to autoimmune diseases and beyond.拓展嵌合抗原受体T细胞疗法的视野:从癌症治疗到自身免疫性疾病及其他领域。
Front Immunol. 2025 Feb 19;16:1544532. doi: 10.3389/fimmu.2025.1544532. eCollection 2025.